News
Young men at highest schizophrenia risk from cannabis abuse
- Author:
- Megan Brooks
For young men aged 21-30, the proportion of preventable schizophrenia cases related to cannabis abuse disorder may be as high as 30%.
News
Asthma tied to increased risk for multiple cancers
- Author:
- Megan Brooks
Treatment with an inhaled steroid may lower that risk, perhaps by keeping inflammation in check.
News
Pausing endocrine therapy to attempt pregnancy is safe
- Author:
- Megan Brooks
The results provide the “strongest evidence to date on the short-term safety of this choice.”
News
H. pylori eradication therapy curbs risk for stomach cancer
- Author:
- Megan Brooks
The study is significant because “it is the first to show this effect in a large, diverse population in the U.S., where gastric cancer incidence...
News
Hearing aids are a ‘powerful’ tool for reducing dementia risk
- Author:
- Megan Brooks
“The evidence is building that hearing loss may be the most impactful modifiable risk factor for dementia in mid-life.”
News
New clues to how air pollution fuels lung cancer in nonsmokers
- Author:
- Megan Brooks
Although smoking remains the chief risk factor for lung cancer, outdoor air pollution causes roughly 1 in 10 cases.
News
10 popular diets for heart health ranked
- Author:
- Megan Brooks
The DASH, Mediterranean, and vegetarian eating patterns align best with current AHA healthy eating guidelines, whereas the paleo and keto diets...
News
AHA backs screening for cognitive impairment after stroke
- Author:
- Megan Brooks
Cognitive impairment is common after a stroke; screening may help detect it early and allow appropriate multidisciplinary care, AHA says.
News
U.S. incidence, prevalence of myasthenia gravis is rising
- Author:
- Megan Brooks
These new estimates are “significantly higher” than those from a prior U.S. analysis from 2003.
News
Head-to-head comparison of migraine meds reveals top options
- Author:
- Megan Brooks
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
News
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
- Author:
- Megan Brooks
Phase 2 data showed that use of the drug resulted in positive changes in plasma and imaging biomarkers of Alzheimer’s disease pathology.
News
FDA expands atogepant approval to include chronic migraine
- Author:
- Megan Brooks
The approval makes atogepant the first, and only, oral CGRP receptor antagonist approved to prevent migraine across frequencies, including...
News
Harnessing ChatGPT to improve liver disease outcomes
- Author:
- Megan Brooks
ChatGPT information is correct, but inadequate.
News
‘Shocking’ data on what’s really in melatonin gummies
- Author:
- Megan Brooks
The investigators found that consuming some products as directed could expose consumers, including children, to doses that are 40-130 times...
News
Ablation for atrial fibrillation may protect the aging brain
- Author:
- Megan Brooks
Adults who had previously undergone catheter ablation were significantly less likely to be cognitively impaired during the 2-year study period,...